Substrates for sudden cardiac death

Christopher L Case1

  • 1Arrhythmia Center, Cook Children's Medical Center, 901 Seventh Avenue, Suite 310, Ft. Worth, TX 76104, USA. ccase@cookchildrens.org

Insights

Identifying cardiac abnormalities before an event is crucial for preventing sudden cardiac death (SCD) in all age groups. Modifying these cardiac substrates is key to SCD prevention strategies, especially in children.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pediatric Cardiology

Background:

  • Sudden cardiac death (SCD) is a significant concern in both pediatric and adult populations.
  • Identifying specific cardiac substrate abnormalities is critical for risk stratification.

Purpose of the Study:

  • To emphasize the importance of pre-event identification of cardiac substrate abnormalities.
  • To highlight the role of substrate modification in preventing sudden cardiac death.

Main Methods:

  • Review of existing literature on cardiac substrate abnormalities and SCD.
  • Analysis of risk factors associated with cardiac substrate abnormalities.
  • Discussion of preventive strategies targeting identified substrates.

Main Results:

  • Certain cardiac substrate abnormalities place individuals at increased risk for SCD.
  • Early identification allows for targeted interventions.
  • Modification of these substrates is a viable prevention strategy.

Conclusions:

  • Pre-event identification of cardiac substrate abnormalities is essential for SCD prevention.
  • Preventive strategies must focus on identifying and modifying at-risk cardiac substrates.
  • This approach is vital for both pediatric and adult populations.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...